Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Advertising and marketing

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Chewy

Chewy, Inc. operates as a pure-play pet e-tailer in the United States. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Dania Beach, FL.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Chewy reports strong Q1 earnings, raises full-year outlook

Chewy's Q1 performance reflects strong net sales growth and margin expansion, driven by Autoship sales and improved gross margin. The company is optimistic about its expansion into Canada and the potential of Lemonade in Chewy Health. However, challenges related to freight costs and potential macro issues may impact future performance.

Chewy reports $2.78B in Q2 net sales, eyes Canadian expansion

Chewy's Q2 2023 earnings call highlighted strong net sales growth, successful initiatives in the Chewy Health platform, and upcoming expansion into the Canadian market. The company is prepared to navigate potential challenges in changing consumer behavior and promotional activity while focusing on driving customer engagement and strategic expansion.

Chewy reports strong Q3 performance, eyes growth in Canada

Chewy's Q3 performance reflects solid growth, particularly in pharmacy sales and customer acquisition during key shopping events. While facing challenges in customer management and strategic planning, the company's expansion into Canada and focus on enhancing customer value present promising opportunities for future growth.

Chewy reports robust Q4 earnings, eyes international expansion for growth

Chewy delivered strong Q4 performance with increased net sales and gross margin expansion, positioning for continued growth in 2023 through supply chain initiatives and margin improvement strategies.
While facing challenges in discretionary categories and market competitiveness, Chewy's focus on international expansion and gross margin expansion presents significant growth opportunities.
The company's emphasis on operational efficiency, customer growth, and margin enhancement underscores its commitment to sustainable growth and profitability in the evolving retail landscape.

Chewy excels in Q1 with strong sales growth and strategic expansions

Chewy's Q1 results showcase strong sales growth, margin efficiency, and strategic expansions. The company remains optimistic about revenue potential, consumer engagement, and operational enhancements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

The AZEK Company

Griffon

GFF, AZEK and CHWY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 22, 2024.

Best Growth Stocks to Buy for February 22nd

Chewy (CHWY) concluded the recent trading session at $17.46, signifying a +0.11% move from its prior day's close.

Chewy (CHWY) Ascends But Remains Behind Market: Some Facts to Note

Investing in this growth stock could deliver fantastic returns for growth stock investors in the long run.

1 Spectacular Growth Stock Down 85% to Buy Hand Over Fist in 2024

JD.com

The e-commerce sector has been a rollercoaster over the past few years, thanks to the ripples created by the pandemic. Many former high-flying stocks now sit at depressed levels after the temporary Covid-19 boom ended and more normal growth resumed.

3 Unstoppable E-Commerce Stocks Set to Soar in 2024

Pfizer

Healthcare and pet spending are often considered nonnegotiable expenses by consumers. Pfizer is dealing with a steep sell-off, but the underlying business should encourage investors.

2 Bargain Basement Stocks to Buy Now and Hold Forever

Chewy stock has fallen another 20% in 2024, making it a potential value stock with room for growth. Chewy is a category leader in the e-commerce pet industry and has opportunities for international expansion and margin expansion through product categories. The company's focus on profitability and recent layoffs could lead to strong margin leverage in 2024, and early Black Friday results suggest better-than-expected performance.

Chewy: Look For Profit Expansion In 2024

Chewy has underperformed in 2023, but the worst is priced in, with potential for significant upside over 5 years. Growing wallet share and higher sales from the Autoship subscription service will continue to drive revenue growth and engagement. Chewy operates in a large and growing market, with opportunities for deeper market penetration and innovation in the Chewy Health category.

Chewy: Time To Dip Your Toes In As Risk-Reward Is Attractive

In the latest trading session, Chewy (CHWY) closed at $16.93, marking a -1.17% move from the previous day.

Chewy (CHWY) Stock Sinks As Market Gains: Here's Why

Novavax

Toast

Toast is growing revenue and payment volume in the double digits. Chewy is expanding into Canada, which could become a significant market for the e-commerce company.

3 Beaten-Down Growth Stocks that Could Take off in the New Bull Market

Duolingo

Language learning and pet spending both represent booming industries ripe for consumer spending. Duolingo is raking in profits, and subscribers are soaring.

2 No-Brainer Growth Stocks to Buy in 2024 and Hold for at Least Five Years

Every day for the next three weeks, we're going to highlight one of Schaeffer's top 12 picks for 2024.

Top Stock Picks for 2024: Chewy

Etsy

Teladoc

Etsy and Chewy are e-commerce businesses that have shown their ability to keep customers coming back -- even during tough times. Teladoc Health has put a new focus on the path to profitability, and its efforts are bearing fruit.

These 2023 Stock Market Losers Could Take Off in 2024

The pet category is booming. Booming more than ever, one could say.

Chewy Health President: New Veterinary Clinics Complete Petcare Ecosystem

This stock is down, but the company is doing better than ever.

1 Hyper Growth Stock Down 84% That You Don't Want to Miss

Amazon

CRISPR Therapeutics

Bear markets always have led to bull markets, so there's reason to be optimistic about the future. To prepare for better market times, buy quality growth stocks -- they generally thrive in strong market environments.

My 5 Top Growth Stocks to Buy Hand Over Fist for 2024

Williams-Sonoma

Chewy, Inc. NYSE: CHWY and Williams-Sonoma NYSE: WSM received upgrades that investors can buy into. Not because a single upgrade is enough to move a market but because these upgrades align with recent trends.

2 eCommerce upgrades that you can buy into

Chewy Inc (NYSE: CHWY) has been a disappointment for its shareholders in recent weeks but a Barclays analyst says it will come back strongly over the next twelve months.

Chewy stock price forecast: Barclays sees a whopping 50% upside

Barclays upgraded Chewy Inc  (NYSE:CHWY) to "overweight" from "equal-weight," and raised its price objective to $30 from $19.

Analyst: Chewy Stock Offers Attractive Entry Point

Apple

Alphabet

Moderna

A well-thought-out portfolio could help you win this year and over time. It's crucial to diversify your investments and invest for the long term.

The Best Places to Invest $100,000 in 2024

Chewy (NYSE: CHWY ) stock is falling on Wednesday after Morgan Stanely (NYSE: MS ) initiated a block sale of the company's shares. This has the block sale including 12.3 million shares of CHWY stock that are being resold by Morgan Stanley for between $20.45 per share and $20.85 per share.

Morgan Stanley Block Sale Sends Chewy (CHWY) Stock Down

Chewy is a dominant player in the e-commerce animal food and products market, with revenues having grown to $11 billion here. The company has seen continued revenue growth but struggles to generate fundamental earnings support due to slim margins. Despite this, Chewy's potential for market share gains and margin expansion in the long term could drive its valuation higher.

Chewy: Taking Another Long-Term Bite

Disney

Toast is trading for less than half of its 2021 IPO price, and restaurant chains are eating up the platform. Revenue growth is slowing and the user base has stalled at Chewy, but don't send the stock to the doghouse just yet.

3 Stocks You'll Be Glad You Bought at These Prices

I still see CHWY as an attractive long-term investment despite weak active customer performance. The company's plans to open veterinary clinics in 2024 enable it to fully address the $47 billion pet health TAM. Autoship, which allows customers to auto-purchase products at predetermined intervals, is a strong growth driver for Chewy.

Chewy: Long-Term Growth Potential Intact With Enlarged TAM

Freshpet

Petstocks like Chewy, Inc NASDAQ: CHWY and Freshpet NASDAQ: FRPT are down significantly from their highs, but the bad times are over. Industry trends and consumer habits are coming back into alignment, putting these discretionary stocks in great shape for the year.

These pet stocks can rebound in 2024

This growth stock is led by a capable management team that has demonstrated improvement in profitability.

News for Chewy Stock (CHWY)